Bringing together clinicians and researchers in the UK working on frontotemporal dementia and associated disorders.
FTDUK is co-ordinated by Professor Jonathan Rohrer (University College London), Professor James Rowe (University of Cambridge), Dr Kathryn Bowles (University of Edinburgh) and Dr Jenna Gregory (University of Aberdeen).
We run an Early Career Researcher prize for FTD researchers – this is open to any researcher who is a research assistant, PhD student or postdoctoral researcher within 5 years of completion of their PhD.
We have been running FTD UK since 2011 and after an absence during the Covid pandemic we returned in 2023 to run our 10th meeting. The meeting remains free to attend and will be in Cambridge this year. Registration is now open and the programme will be posted here in February.
We are very thankful to Alzheimer’s Research UK and the Guarantors of Brain who have kindly helped to fund the event each year through conference grants, and to the Alzheimer’s Society who have funded the Early Career Researcher Prize awards.
2024 – 11th Annual Meeting – Cambridge – 15th May
9.30am | Registration | |
10.00am | Welcome to the meeting and introduction | |
10.10am | Multidimensional insights into FTD cognition | Matt Lambon-Ralph (University of Cambridge) |
10.30am | Digital biomarkers and remote monitoring in FTD | Rhian Convery (UCL) |
10.50am | The surprising amyloid found in FTLD-FUS | Tammaryn Lashley (UCL) |
11.10am | Coffee break | |
11.40am | TBK1 loss-of-function is associated with cell autonomous microglial dysfunction | Owen Peters (Cardiff University) |
12.00pm | Stress-induced nuclear TDP-43 pathology leads to STMN2 depletion: an early pathological event in FTD/ALS? | Anna Sanchez Avila (University of Sheffield) |
12.20pm | Investigating subcellular and secreted interactomes of pathological tau: lessons from extracellular vesicles | Steph Fowler (University of Oxford) |
12.40pm | Lunch | |
1.40pm | Update on FTD and dementia consortia | FTD UK team |
2.00pm | Mining the immune system for protective antibodies in neurodegenerative diseases | Ralph Minter (Alchemab Therapeutics) |
2.20pm | Autologous HSC gene therapy for the treatment of FTD-GRN | Chiara Recchi (Orchard Therapeutics) |
2.40pm | Coffee break | |
3.10pm | Alzheimer's Society ECR prizes - introduction and award | |
3.30pm | Basic Science Prize for Early Career UK FTD Researcher sponsored by the Alzheimer's Society | |
3.40pm | Clinical Science Prize for Early Career UK FTD Researcher sponsored by the Alzheimer's Society | |
3.50pm | Summary | |
4.00pm | Finish |